US loss of exclusivity · Oncology

Tecentriq

Roche

2028US biosimilars from
2025Today: 20262037
2025 worldwide sales
≈$4.3B
Date basis
Patent-expiry estimate
US biosimilars
No US filing found
Pharma Patent Cliff by readouts.io Data checked 8 October 2026 · Full Tecentriq timeline →